Brain Tumor Survivors Map Their Shifting Symptom Journey From Diagnosis to Daily Life

A brain tumor diagnosis does not simply introduce a fixed set of symptoms that patients learn to endure. According to a new longitudinal study published in Supportive Care in Cancer, the symptom experience of people living with glioma is a moving target, one that shifts in character and intensity from the moment of diagnosis through surgery and into the fragile months of recovery. Researchers led by Xiao-jing Meng and Zi-chen Zhang of Henan Provincial People’s Hospital in Zhengzhou, China, followed twelve glioma survivors across three time points to capture how patients perceive, interpret, and cope with their symptoms as their lives are upended. Their conclusion is stark: the symptom journey is not static but a complex trajectory marked by significant and evolving burdens, one that current healthcare systems are poorly equipped to address.

Gliomas, which arise from neuroepithelial cells, are the most common primary malignant tumors of the central nervous system, accounting for roughly 50 to 60 percent of all intracranial tumors. The World Health Organization’s 2021 classification divides them into four grades, with grades one and two considered low-grade and grades three and four high-grade. Even with standardized treatment combining surgery, concurrent chemoradiotherapy, and adjuvant chemotherapy, the median overall survival for patients with WHO grade IV malignant glioma remains under two years, and the five-year survival rate is only about ten percent. Because grading relies primarily on tumor morphology, patients with identical grades can still face markedly different prognoses, adding a layer of uncertainty that shadows every stage of care.

The study’s methodology was deliberately designed to capture change over time. Using a descriptive phenomenological approach grounded in the philosophical tradition of Husserl, the team conducted semi-structured interviews at three points: at initial diagnosis, one month after surgery, and three months after surgery. Twelve survivors, numbered P1 through P12, were recruited through purposive sampling at a large tertiary Grade A specialized cerebrovascular hospital in Central China between November 2024 and November 2025. The median age was 51 years, with a range of 31 to 69, and 58.4 percent were men. Data saturation was reached with the eleventh participant, and a twelfth was interviewed to confirm that no new themes were emerging. Interviews lasted between 30 and 60 minutes and were conducted in quiet, undisturbed spaces, with researchers recording nonverbal cues such as speech rate, tone, facial expressions, and body movements.

Transcripts were analyzed using Colaizzi’s method, a structured seven-step procedure in which researchers repeatedly read the records, extract meaningful statements related to symptom experience, condense them into units of meaning, and cluster similar content into themes. Transcripts were verified by a second researcher within 24 hours and sent back to participants for confirmation. Two researchers independently coded and analyzed the data, and regular team meetings compared interpretive approaches and examined subjective assumptions to minimize bias. The analysis yielded four core themes: self-perception and interpretation of the disease, differentiated coping with symptoms, practical dilemmas in symptom management, and core needs in symptom management.

The first theme traces how symptoms announce themselves and how patients make sense of them. Because glioma symptoms are dictated by tumor size, location, and growth rate, presentations varied widely. One 68-year-old man described a relentless headache paired with constant nausea that left him unable to eat, while a 60-year-old man spoke of a swollen left hand and foot, walking as if stepping on cotton, and a fear of falling that forced him to rely on family for basic care. Hospitalization added its own physiological challenges, with patients reporting pain during drainage tube removal, dressing changes, and wound suturing. Notably, despite this discomfort, most patients cooperated actively with nursing care, and some, like a 57-year-old man facing nasogastric tube insertion, recognized the clinical necessity of the intervention and chose to endure it.

Coping strategies diverged sharply along two paths. Some patients adopted a positive mindset, perceiving the illness as understandable and controllable, and proactively sought reliable resources. A 69-year-old man expressed complete confidence in his doctors’ expertise and the hospital’s advanced technology, certain that full cooperation would speed his recovery. Optimism proved contagious: the same ward’s patients, ranging from a six-year-old child to people over 80, inspired one another with their resilience. Others sank into negative coping. A 52-year-old woman sighed that her family’s business had been suspended, no one could care for the children, and everything now centered on her, making her feel like a burden to the whole family. Fear of seizures kept one participant from ever going out alone, while another lay awake each night terrified of recurrence, and a third avoided relatives and friends to escape gossip about her brain tumor, gradually losing all desire to interact with anyone.

The third theme exposed a web of practical dilemmas that the researchers describe as a vicious cycle of insufficient cognition, limited treatment, economic loss, and social isolation. Most patients had limited understanding of glioma prevention and management, relying predominantly on the internet for information rather than systematic, personalized guidance. One man worried aloud whether an injection or his pre-admission aspirin would interfere with upcoming surgery; another had read online that a second relapse would be serious and could not stop worrying. Diagnostic difficulties compounded the distress, with one patient reporting that different hospitals gave different test results and none could offer a definite diagnosis. Financial pressure was crushing: one 32-year-old father had already spent over 100,000 yuan on treatment in Beijing and expected to spend another 70,000 to 80,000 yuan. Work limitations followed, with one 41-year-old man reporting that no company would hire him for fear he would suddenly fall ill on the job.

Against these burdens, patients articulated two core needs. The first is for health-related information: personalized treatment plans, clear follow-up protocols, and home-based rehabilitation guidance. Patients asked whether they would receive follow-up care after discharge, what the specific process would be, and how to care for themselves at home. The second is for diverse, multi-level support: emotional comfort from family and peers, professional care from clinicians, and social and economic resources. One man described how chatting with friends eased his anxiety, while a woman said earnest family conversations left her feeling particularly at peace. Another participant noted that when her headache became unbearable, doctors and nurses patiently showed her what to do and even chatted to lift her spirits, after which the pain felt far less severe. Economic support emerged as the most urgent social demand, alongside hopes for mutual assistance among patients.

The discussion section argues that these findings, which extend the team’s earlier cross-sectional work, demand a fundamental reorientation of care. Because specialists typically provide only phased, targeted treatment, the authors contend that clinical nurses, who maintain uninterrupted contact across the entire disease course, are best positioned to lead a psychosocial oncology care system tailored to China’s conditions, coordinating multiple medical teams, integrating services into individualized care, and conducting continuous needs assessment and long-term follow-up. They recommend replacing one-size-fits-all education with bedside one-on-one guidance, short videos, and peer experience sharing, and optimizing bed reservation systems, multi-hospital information sharing, and standardized multidisciplinary team protocols to reduce delays. The sensitive transition from hospital to home, they emphasize, requires telephone calls, text messages, or home visits to track symptoms, offer professional advice, and sustain emotional companionship.

The authors acknowledge the study’s limitations candidly. All twelve participants were recruited from a single tertiary hospital in Henan Province, so the findings cannot be generalized to patients elsewhere in the world or treated at other hospitals, and most participants had low incomes and education levels, limiting representativeness for wealthier or more educated groups. Possible confirmation bias and missing data also qualify the results. Yet the study makes a significant contribution to the qualitative literature on Chinese glioma patients, illuminating how the disease reshapes not only bodies but family roles, social standing, and the very possibility of a normalized life. Its central message resonates far beyond one hospital: survivorship care must become longitudinal, patient-centered, and responsive to needs that change month by month, or patients will continue to navigate an evolving symptom burden largely alone.

Subject of Research: Longitudinal qualitative study of symptom trajectories and care needs in glioma survivorship

Article Title: From diagnosis to daily realities: longitudinal phenomenological exploration of symptom trajectories in glioma survivorship

Article References: Meng, X.-J., Zhang, Z.-C., Xiang, L., Min, G., & Li, L.-M. (2026). From diagnosis to daily realities: longitudinal phenomenological exploration of symptom trajectories in glioma survivorship. Supportive Care in Cancer, 34(10), Article 994. https://doi.org/10.1007/s00520-026-11200-0

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11200-0

Keywords: glioma, brain cancer, survivorship, symptom management, phenomenology, qualitative research, quality of life, nursing, coping strategies, patient needs, longitudinal study, supportive care